| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |